← Leaderboards
Elke Bergmannleitner
Geneva Foundation
$391,530
Attributed
$783,059
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $441.2K · FY2022–23$500K$375K$250K$125K$0
'22
'23
Funding mix
By agency
NIH$783,059 · 2
By mechanism
R21$783,059 · 2
Top collaborators
- Rupsa Chaudhury Boelig2 shared
- Sean Phillip Riley2 shared
Others in their field
Other Rising Stars on “Communicable Diseases”
- Mari Ostendorf · University Of Washington$51,931,230
- Calvin Proffitt · Leidos Biomedical Research, Inc.$24,262,802
- Kevin Saunders · Duke University$18,106,404
- Bambra Stokes · Ppd Development Lp$17,155,112
- Dennis Eyler · Fisher Bioservices, Inc.$15,841,540
- Cynthia M Visness · Rho Federal Systems Division, Inc.$14,006,776
Research focus
Communicable DiseasesData AnalysesSerumResponseImmunologyFrequenciesImmuneFutureImmunityMachine LearningVaccinesInfectionBiomarker IdentificationImmune ResponseCohortCollaborationsBacterial InfectionsBacteriaAnimal ModelArtificial IntelligenceBody Weight DecreasedAntigensAnimal Disease ModelsAcquired Immunity
Grant awards (4)
Identification of Genetic Markers of Susceptibility to Intracellular Bacterial Infection Using the Collaborative Cross Mouse Model$171,704
R21 · FY2023 · AI · contact PI
Serological and functional impact of COVID-19 vaccination on the maternal fetal unit and infant immunity$170,141
R21 · FY2023 · HD
Serological and functional impact of COVID-19 vaccination on the maternal fetal unit and infant immunity$225,781
R21 · FY2022 · HD
Identification of Genetic Markers of Susceptibility to Intracellular Bacterial Infection Using the Collaborative Cross Mouse Model$215,433
R21 · FY2022 · AI · contact PI